A citation-based method for searching scientific literature

J A Johnson, L Gong, M Whirl-Carrillo, B F Gage, S A Scott, C M Stein, J L Anderson, S E Kimmel, M T M Lee, M Pirmohamed, M Wadelius, T E Klein, R B Altman. Clin Pharmacol Ther 2011
Times Cited: 438







List of co-cited articles
763 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity.
Julián G Chamorro, Jorge P Castagnino, Omar Aidar, Rosa M Musella, Ana Frías, Mabel Visca, Mabel Nogueras, Lucas Costa, Alessandro Perez, Fabio Caradonna,[...]. Pharmacogenet Genomics 2017
10
10

Translational genomics and precision medicine: Moving from the lab to the clinic.
Eleftheria Zeggini, Anna L Gloyn, Anne C Barton, Louise V Wain. Science 2019
69
1

Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
A G Vandell, C W McDonough, Y Gong, T Y Langaee, A M Lucas, A B Chapman, J G Gums, A L Beitelshees, K R Bailey, R J Johnson,[...]. J Intern Med 2014
22
4




Radiomics, machine learning, and artificial intelligence-what the neuroradiologist needs to know.
Matthias W Wagner, Khashayar Namdar, Asthik Biswas, Suranna Monah, Farzad Khalvati, Birgit B Ertl-Wagner. Neuroradiology 2021
10
10

Improving reporting standards for polygenic scores in risk prediction studies.
Hannah Wand, Samuel A Lambert, Cecelia Tamburro, Michael A Iacocca, Jack W O'Sullivan, Catherine Sillari, Iftikhar J Kullo, Robb Rowley, Jacqueline S Dron, Deanna Brockman,[...]. Nature 2021
103
1

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.
Jasper Jan Brugts, Aaron Isaacs, Eric Boersma, Cock M van Duijn, Andre G Uitterlinden, Willem Remme, Michel Bertrand, Toshiharu Ninomiya, Claudio Ceconi, John Chalmers,[...]. Eur Heart J 2010
58
1

Benefits and limitations of genome-wide association studies.
Vivian Tam, Nikunj Patel, Michelle Turcotte, Yohan Bossé, Guillaume Paré, David Meyre. Nat Rev Genet 2019
547
1

Replication - why we need to publish our findings.
Michael J Curtis, Darrell R Abernethy. Pharmacol Res Perspect 2015
6
16

Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.
A Custodio, J Moreno-Rubio, J Aparicio, J Gallego-Plazas, R Yaya, J Maurel, O Higuera, E Burgos, D Ramos, A Calatrava,[...]. Ann Oncol 2014
41
2

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?
Federico Nichetti, Felicia Stefania Falvella, Rosalba Miceli, Stefania Cheli, Raffaella Gaetano, Giovanni Fucà, Gabriele Infante, Antonia Martinetti, Carlotta Antoniotti, Alfredo Falcone,[...]. Pharmacogenomics J 2019
13
7

Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA.
Joep van der Leeuw, Rohit M Oemrawsingh, Yolanda van der Graaf, Jasper J Brugts, Jaap W Deckers, Michel Bertrand, Kim Fox, Roberto Ferrari, Willem J Remme, Maarten L Simoons,[...]. Int J Cardiol 2015
8
12

Validation and updating of predictive logistic regression models: a study on sample size and shrinkage.
Ewout W Steyerberg, Gerard J J M Borsboom, Hans C van Houwelingen, Marinus J C Eijkemans, J Dik F Habbema. Stat Med 2004
362
1

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation.
María José Serna, José Miguel Rivera-Caravaca, Rocío Gonzalez-Conejero, María Asunción Esteve-Pastor, Mariano Valdés, Vicente Vicente, Gregory Y H Lip, Vanessa Roldán, Francisco Marín. Eur J Clin Invest 2018
2
50

Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy.
Marta Spreafico, Corrado Lodigiani, Y van Leeuwen, Denise Pizzotti, Lidia L Rota, Fr Rosendaal, Pier M Mannucci, Flora Peyvandi. Pharmacogenomics 2008
36
2

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
Sara Gagno, Mario Rosario D'Andrea, Mauro Mansutti, Chiara Zanusso, Fabio Puglisi, Eva Dreussi, Marcella Montico, Paola Biason, Erika Cecchin, Donatella Iacono,[...]. Clin Breast Cancer 2019
6
16

Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.
Federico Innocenti, Deanna L Kroetz, Erin Schuetz, M Eileen Dolan, Jacqueline Ramírez, Mary Relling, Peixian Chen, Soma Das, Gary L Rosner, Mark J Ratain. J Clin Oncol 2009
193
1

Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach.
Jorge Duconge, Ednalise Santiago, Dagmar F Hernandez-Suarez, Mariangeli Moneró, Andrés López-Reyes, Marines Rosario, Jessicca Y Renta, Pablo González, Laura Ileana Fernández-Morales, Luis Antonio Vélez-Figueroa,[...]. Clin Transl Sci 2021
7
14

Pharmacogenetics in clinical pediatrics: challenges and strategies.
Sara L Van Driest, Tracy L McGregor. Per Med 2013
13
7

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
Judith A M Wessels, Sjoerd M van der Kooij, Saskia le Cessie, Wietske Kievit, Pilar Barerra, Cornelia F Allaart, Tom W J Huizinga, Henk-Jan Guchelaar. Arthritis Rheum 2007
184
1

Evaluation of the incremental prognostic value of the combination of CYP2C19 poor metabolizer status and ABCB1 3435 TT polymorphism over conventional risk factors for cardiovascular events after drug-eluting stent implantation in East Asians.
Mahn-Won Park, Sung Ho Her, Chan Joon Kim, Jung SunCho, Gyung-Min Park, Tae-Seok Kim, Yun-Seok Choi, Chul-Soo Park, Yoon-Seok Koh, Hun-Jun Park,[...]. Genet Med 2016
9
11


CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureas.
G Ragia, A Tavridou, L Elens, R H N Van Schaik, V G Manolopoulos. Exp Clin Endocrinol Diabetes 2014
22
4

Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
Silvia Triarico, Alberto Romano, Giorgio Attinà, Michele Antonio Capozza, Palma Maurizi, Stefano Mastrangelo, Antonio Ruggiero. Int J Mol Sci 2021
14
7

Cancer treatment and survivorship statistics, 2019.
Kimberly D Miller, Leticia Nogueira, Angela B Mariotto, Julia H Rowland, K Robin Yabroff, Catherine M Alfano, Ahmedin Jemal, Joan L Kramer, Rebecca L Siegel. CA Cancer J Clin 2019
1

Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.
Henk Visscher, Colin J D Ross, S Rod Rassekh, Amina Barhdadi, Marie-Pierre Dubé, Hesham Al-Saloos, George S Sandor, Huib N Caron, Elvira C van Dalen, Leontien C Kremer,[...]. J Clin Oncol 2012
269
1

Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
Kaoru Suzuki, Yoichi Kakuta, Takeo Naito, Tetsuya Takagawa, Hiroyuki Hanai, Hiroshi Araki, Yu Sasaki, Hirotake Sakuraba, Makoto Sasaki, Tadakazu Hisamatsu,[...]. Inflamm Bowel Dis 2022
3
33

Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.
Rohit M Oemrawsingh, K Martijn Akkerhuis, Laura C Van Vark, W Ken Redekop, Goran Rudez, Willem J Remme, Michel E Bertrand, Kim M Fox, Roberto Ferrari, A H Jan Danser,[...]. J Am Heart Assoc 2016
11
9

Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes.
Kimberly Guinan, Catherine Beauchemin, Johanne Tremblay, John Chalmers, Mark Woodward, Muhammad Ramzan Tahir, Pavel Hamet, Jean Lachaine. Can J Diabetes 2021
5
20

Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention.
Anchit Bhagat, Eugenie S Kleinerman. Adv Exp Med Biol 2020
35
2

Prediction of Warfarin Dose in Pediatric Patients: An Evaluation of the Predictive Performance of Several Models.
Elizabeth Marek, Jeremiah D Momper, Ronald N Hines, Cheryl M Takao, Joan C Gill, Vera Pravica, Andrea Gaedigk, Gilbert J Burckart, Kathleen A Neville. J Pediatr Pharmacol Ther 2016
4
25

Big data and machine learning algorithms for health-care delivery.
Kee Yuan Ngiam, Ing Wei Khor. Lancet Oncol 2019
277
1

Cytochrome P450 Genetic Variations Can Predict mRNA Expression, Cyclophosphamide 4-Hydroxylation, and Treatment Outcomes in Chinese Patients With Non-Hodgkin's Lymphoma.
Wenying Shu, Lingyan Chen, Xiaoye Hu, Meimei Zhang, Wensheng Chen, Lei Ma, Xiaoyan Liu, Jianing Huang, Tingyuan Pang, Jia Li,[...]. J Clin Pharmacol 2017
12
8

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.
Yoshiaki Yamamoto, Ryouichi Tsunedomi, Yusuke Fujita, Toru Otori, Mitsuyoshi Ohba, Yoshihisa Kawai, Hiroshi Hirata, Hiroaki Matsumoto, Jun Haginaka, Shigeo Suzuki,[...]. Oncotarget 2018
4
25

Publication bias: what are the challenges and can they be overcome?
Ridha Joober, Norbert Schmitz, Lawrence Annable, Patricia Boksa. J Psychiatry Neurosci 2012
134
1

Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland.
Sini Kerminen, Alicia R Martin, Jukka Koskela, Sanni E Ruotsalainen, Aki S Havulinna, Ida Surakka, Aarno Palotie, Markus Perola, Veikko Salomaa, Mark J Daly,[...]. Am J Hum Genet 2019
51
1

Prediction of optimal warfarin maintenance dose using advanced artificial neural networks.
Enzo Grossi, Gian Marco Podda, Mariateresa Pugliano, Silvia Gabba, Annalisa Verri, Giovanni Carpani, Massimo Buscema, Giovanni Casazza, Marco Cattaneo. Pharmacogenomics 2014
32
3

Tutorial: a guide to performing polygenic risk score analyses.
Shing Wan Choi, Timothy Shin-Heng Mak, Paul F O'Reilly. Nat Protoc 2020
334
1

Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes.
Yusheng Zhu, Michael Shennan, Kristen K Reynolds, Nancy A Johnson, Matthew R Herrnberger, Roland Valdes, Mark W Linder. Clin Chem 2007
160
1

Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients.
Ji-Ye Yin, Xi Li, Xiang-Ping Li, Ling Xiao, Wei Zheng, Juan Chen, Chen-Xue Mao, Chao Fang, Jia-Jia Cui, Cheng-Xian Guo,[...]. Cancer Lett 2016
20
5

[The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].
C-M Schmidt, E Bartholomäus, D Deuster, A Heinecke, A G Dinnesen. HNO 2007
36
2

Genetic analyses of diverse populations improves discovery for complex traits.
Genevieve L Wojcik, Mariaelisa Graff, Katherine K Nishimura, Ran Tao, Jeffrey Haessler, Christopher R Gignoux, Heather M Highland, Yesha M Patel, Elena P Sorokin, Christy L Avery,[...]. Nature 2019
322
1

A brief history of human disease genetics.
Melina Claussnitzer, Judy H Cho, Rory Collins, Nancy J Cox, Emmanouil T Dermitzakis, Matthew E Hurles, Sekar Kathiresan, Eimear E Kenny, Cecilia M Lindgren, Daniel G MacArthur,[...]. Nature 2020
197
1

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors.
Tibor Hlavaty, Marc Ferrante, Liesbet Henckaerts, Marie Pierik, Paul Rutgeerts, Severine Vermeire. Inflamm Bowel Dis 2007
53
1

Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.
P Impicciatore, I Choonara, A Clarkson, D Provasi, C Pandolfini, M Bonati. Br J Clin Pharmacol 2001
297
1


Genetic predisposition and nongenetic risk factors of thiazolidinedione-related edema in patients with type 2 diabetes.
Tien-Jyun Chang, Pi-Hua Liu, Yi-Chi Liang, Yi-Cheng Chang, Yi-Der Jiang, Hung-Yuan Li, Min-Tzu Lo, Harn-Shen Chen, Lee-Ming Chuang. Pharmacogenet Genomics 2011
15
6

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
373
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.